Title : Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway.

Pub. Date : 2015 Oct

PMID : 26248946






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway. Imatinib Mesylate CD34 molecule Homo sapiens
2 Furthermore, PI3K inhibitors also significantly sensitized CML CD34+ cells to imatinib-induced apoptosis. Imatinib Mesylate CD34 molecule Homo sapiens
3 These findings indicate that miR-21 is required for maintaining the imatinib-resistant phenotype of CML CD34+ cells through PI3K/AKT signaling pathway, thus providing the basis for a promising therapeutic approach to eliminate CML LSCs. Imatinib Mesylate CD34 molecule Homo sapiens